Goldman Sachs lowered the firm’s price target on Stryker (SYK) to $422 from $427 and keeps a Neutral rating on the shares. The firm is updating its model to reflect the company’s Inari acquisition and the $3B of debt taken on to fund the acquisition, the analyst tells investors in a research note. Goldman adds however that following the deal, it sees 2025-2028 revenue growth of 8.2% vs. 7.9% previously.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK: